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Review Article
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Abstract: Nipple sparing mastectomy (NSM) has quickly become an accepted technique for patients
with selected cancers and for risk reducing surgery. Much of its surgical acceptance over the last decade
has been based on the low risk of nipple areolar complex (NAC) occurrence in breast cancer patients.
Improved patient satisfaction due to improved cosmetic outcomes with reconstruction have also driven
its popularity. We reviewed current English journals to determine the NSM techniques which achieve the
lowest complications, best outcomes, and best patient satisfaction. We researched studies showing reductions
in complications with improved surgical techniques and patient selection which have been implicated in
improved results. In the studies reviewed, incision placement, away from the nipple, resulted in the lowest
rates of ischemic nipple complications and the best cosmetic outcomes. The effect of other factors such as
surgeon experience and thickness of skin flap development were more difficult to prove. Leaving a 2–3 mm
rim of tissue around the nipple bundle was shown to help preserve the nipple vascularity. Lower complication
rates with improved outcomes and patient satisfaction were reported in the literature in patients with B or
smaller cup sizes, non-smokers, and patients with lower body mass index (BMI). Incision placement, away
from the nipple, with preservation of a 2–3 mm rim of tissue around the nipple bundle along with careful
patient selection were the most significant variables reviewed which helped to lower complications rates of
NSM. Coordinated surgical planning with the breast and plastic surgeons to determine the best surgical
approach for each individual patient is necessary to obtain the best results. Although short-term oncologic
follow-up seems to be acceptable, longer follow-up will still be needed to define the best breast cancer
surgical candidates for the nipple sparing approach.
Keywords: Nipple sparing mastectomy technique; nipple sparing mastectomy complications; nipple sparing
mastectomy cosmesis; nipple sparing mastectomy satisfaction; nipple sparing mastectomy incisions; nipple sparing
mastectomy vascular supply
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Introduction
Less aggressive surgical management of breast cancer
patients has made major advances over the last 3 decades
with the rebuke of the Halstedian concept to acceptance of a
more systemic approach to the management of breast cancer
patients. Surgery has become more conservative starting
with Bernie Fisher’s proven concept of breast conservation
in the 1980’s and then the advent of sentinel lymph node
(SLN) evaluations and skin sparing mastectomies in the
1990’s. With studies proving the low risk of nipple areolar
complex (NAC) involvement in select cancer patients (1-3)
and the new genetic era of breast cancer risk, it was only
natural that nipple sparing techniques would be developed
in the late 1990’s and at the turn of the century. In 1999,
Lynn Hartmann’s paper (4) in the NEJM showed the benefit
for prophylactic, or better termed risk reducing nipple
sparing mastectomy (NSM), in high risk patients with a
90% reduction in breast cancer development. This first
started the movement towards the nipple sparing approach.
Meijers-Heijboer’s later study (5) in the NEJM along with
other publications (6-9) then proved the advantages of risk
reducing mastectomy in BRCA + patients. These cancer
reduction benefits along with the improved aesthetic
outcome from optimal breast contouring with minimal
scarring and improved patient satisfaction led to the NSM’s
quick acceptance and implementation into breast surgery
practices.
The use of the NSM in cancer patients is more
controversial and though it has become standard practice
in many early stage cancer patients, who require or request
a mastectomy, there are no controlled clinical trials
evaluating its effectiveness. The initial use of the nipple
sparing approach was spurred by evidence showing a low
risk of NAC involvement in the pathological mastectomy
specimens of smaller cancers (less than 2 cm) which are node
negative, more peripherally located (>2 cm from the nipple),
and localized (1-3) (Table 1). This led various institutions
to begin performing NSMs in this well-defined lower risk
group of breast cancer patients with good short-term cancer
outcomes (10-13). This has now progressed to the expansion
of eligibility criteria with some institutions advocating for
its use in higher risk patients with larger tumors, tumors
close to the nipple, or even in patients with more aggressive
cancers after neoadjuvant chemotherapy (14). Its utilization
has also increased with the greater use of mastectomy and
contralateral prophylactic mastectomy (15,16) especially
in the younger aged breast cancer population (17,18). To
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date, only one meta-analysis (19) has critically analyzed
overall survival (OS), disease-free survival (DFS), and local
recurrence (LR) in cancer patients who underwent NSM
showing no significant differences compared to women
undergoing modified radical mastectomy (MRM) or skin
sparing mastectomy (SSM). This meta-analysis is limited
in that it focuses mainly on short-term follow-up studies
in earlier stage cancer patients. The American Society of
Breast Surgeons (ASBS) currently has an on-going registry
trial tracking NSM patients throughout the United States
to help better define patient outcomes and eligibility criteria
in the future.
In this review, we have attempted to search for the best
studies of the NSM approach to determine the optimum
technique with the lowest complication rates, trying
to identify the technical causes of the most common
complications and the best methods to avoid them. We
focused on studies evaluating surgeon specific variables as
well as patient variables which help to reduce post-operative
complications. We only briefly mention the clinical
oncologic indications for the procedure and cancer specific
outcome data as well as specific reconstruction technique
unless it had some bearing on overall complication or
outcome since these topics are being described elsewhere in
this journal edition.
Methods
We researched articles using MEDLINE and PubMed
using the MeSH headings for “nipple sparing or total SSM,
technique, complications, outcomes, or satisfaction”. We
performed a world-wide search of all English language
journals. We chose relevant articles which focused mainly
on technical factors including complications and patient
satisfaction.
Results
SLN biopsy in prophylactic surgery
The use of SLN biopsy in prophylactic surgery has been
studied in at least three separate institutional studies
showing the frequency of occult cancer in prophylactic
mastectomy patients to be less than 10% with the majority
of the occult cancers found to be ductal carcinoma in situ
(DCIS) (20-22) (Table 2). The rate of occult invasive cancers,
being less than 5%, does not justify the use of routine SLN
biopsy for patients undergoing nipple sparing mastectomies
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Table 1 Occult nipple areolar cancer involvement
Studies

Years

Number of mastectomy specimens

Nipple areolar complex involvement (%)

Laronga et al. (1)

1999

246

5.6

Simmons et al. (3)

2002

217

10.6

Lagios et al. (2)

1979

149

30.2*

*, 95% of tumors <2.5 cm from the nipple.

Table 2 Incidence of breast cancer in prophylactic mastectomy specimens
Institutions

Study years

Number of
patients

Number of invasive
cancers (%)

Number of noninvasive
cancers (%)

Soran et al. (22)

UPMC

1999–2004

155

2 patients (1.3)

3 patients (1.9)

Black et al. (21)

Mass General

1999–2005

173

5 patients (2.9)

14 patients (8.1)

Boughey et al. (20)

MD Andersen

2000–2005

409

8 patients (2.0)

14 patients (3.4)

Authors

in the prophylactic setting.
Incision placement
Various incision locations have been described for NSMs
with individual surgeons or institutions tending to favor
certain approaches (23-27). The incisions used most
frequently were best evaluated by Endara et al. (26) who
analyzed 48 pooled NSM studies from the literature with 41
studies describing the mastectomy incision and 11 studies
evaluable for outcomes by incision type which found the
most common incision used was a radial approach (46%)
followed by the periareolar (27%), and the Inframammary
incision (21%). The Endara et al. (26) study also looked
at nipple necrosis rates associated with incision placement
in the same 11 studies which included 543 procedures and
found the lowest rates of nipple necrosis in the incisions
involving the least circumference of the nipple (radial
incision, 8.83%; inframammary, 9.09%; periareolar/
circumareolar, 17.81% and transareolar, 81.82%). Increased
risk of nipple areolar necrosis associated with periareolar
incisions was also seen in an Italian study by Salgarello
et al. (28) where it was seen as an early complication in 4 of
the breasts [9.5% (4/42) of total NSMs] with periareolar
incisions but in none of the 22 breasts with radial incisions
undergoing NSM from 2004 to 2009.
An earlier single institution study which evaluated
incision location and nipple necrosis rates was performed
at University of California, San Francisco (UC-SF) and
published by Wijayanayagam et al. (29) and Garwood
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et al. (13) and reported two general types of incisions
crossing either >30% of the NAC (NAC crossing,
mastopexy, nipple free grafts) or <30% of the NAC
(inframammary, radial, or lateral/inferolateral) (Figure 1).
Patients were divided into 2 cohorts, an earlier group of
64 NSM procedures from 2001 to 2005 where more NAC
crossing incisions were performed vs. a later cohort of 106
NSM procedures from 2005 to 2007 where fewer NAC
crossing incisions were performed. There was a significant
increase in nipple survival rates (80–95%, P=0.003) and
decrease in necrotic complications (30–13%, P=0.01) in the
later cohort. A further follow-up study by Warren Peled
et al. (11) from UC-SF compared their first 100 NSM
cases with the following 557 NSM cases and continued
to show decreased complications involving both nipple
and mastectomy flap necrosis as well as reductions in
expander/implant loss which they again attributed to fewer
NAC crossing incisions (mainly inframammary or limited
superior areolar incisions) as well to reduced use of direct
to implant reconstruction and the selective use of acellular
dermal matrixes (ADMs) during reconstruction.
Overall cosmetic and satisfaction outcomes as related
to incision types have been reported but not statistically
analyzed by a few individual studies (23,25,30-33). A
retrospective study by Djohan et al. (32) best evaluated
cosmesis and patient satisfaction using postop questionnaires
of 78 patients as well as independent observer opinions.
Seventy-three percent of the patients stated that they would
undergo the surgery again. Decreased nipple sensation/
arousal was the most common complaint followed by lateral
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Figure 1 Nipple sparing mastectomy incisions. (A,B,C,D) Incisions encompassing >30% of NAC: (A) circumareolar-free nipple grafting;
(B) periareolar mastopexy; (C,D) nipple crossing. (E,F,G) incisions encompassing <30% of NAC: (E) inframammary; (F) inferolateral; (G)
periareolar with or without lateral radial extension [reproduced with permission from Garwood et al. (13)]. NAC, nipple areolar complex.

displacement of the nipple. Nipple displacement was felt
to be related to the radial incision used for the majority of
the NSMs and was related to scar contraction. A separate
study by Wagner et al. (30) evaluated cosmetic outcomes
of 26 patients who underwent NSM through independent
evaluations by two plastic surgeons 6 months after surgery.
There was an acceptable (excellent, very good, or good)
appearance in the breasts of 73.1% of the patients and in
the NAC of 55.8% of the patients. The biggest cosmetic
problem was described as lateral displacement of the nipple
in 67.4% of patients or lateral displacement of the breast
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in 50% of the patients and this was felt to be due to the
lateral incision placements in the majority (79.6%) of the
patients. Other single institution studies have suggested
that keeping the incisions in the inframammary (25) or
inferolateral (23,34) positions (away from the nipples)
does not result in nipple lateralization and also offers
better concealment of the incision. Moyer et al. (33)
reported on a retrospective database evaluation of NSMs
in 26 patients (40 NSMs) performed from 2009 to 2010
where postoperative photographs were evaluated by four
reviewers. Circumareolar incisions were associated with a
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Table 3 Contribution of chest wall arterial vasculature to the NAC with associated vascular pedicle territories
Arterial supply

O’Dey et al. (36) (%)

van Deventer (35) (%)

Internal thoracic artery: medial pedicle

86

100

Lateral thoracic artery: lateral pedicle

100

70

Anterior intercostal branches: medial and inferior pedicle

71

74

Thoracoacromial high thoracic artery: superior pedicle

57

7.4

N/A

4

Posterior intercostal branches: lateral and inferior pedicle
NAC, nipple areolar complex; N/A, not available.

nipple necrosis rate of 75% compared with 33% for radial
incisions and 27% for inframammary incisions and were
related to worse aesthetic evaluations. Not one of these
studies was set up to statistically evaluate the cosmesis and
satisfaction rates of NSM independent of the incision type
and they are just single institution observations.
Preserving the vasculature
The maintenance of the NAC viability and skin flap
perfusion has been studied in past female breast cadaveric
studies by van Deventer et al. (35) and O’dey et al. (36).
The NAC gets the majority of its blood supply from the
internal thoracic vessel with its medial perforators and the
lateral thoracic vessel (Table 3). O’dey et al. (36) suggested
that medial and lateral based pedicle flaps (superomedial
and superolateral) may provide the best blood supply to
the nipple which would favor a more inferior incision to
preserve these pedicles. If a radial incision is used then a
more lateral incision would be favored to help preserve as
much of the internal thoracic blood supple coming off the
medial flap as possible. A full-thickness glandular dermal
skin flap dissection, leaving much of the subdermal fat, was
also felt to be beneficial for vascular preservation as opposed
to a thinner split-thickness lipo-dermal flap, where more of
the subdermal fat is removed.
Preservation of the NAC
We found no studies that were designed to determine
exactly how to handle the thickness of tissue left under the
NAC with different surgeons applying different techniques
and strategies. Studies have not been specifically controlled
to determine if either everting and coring the nipple to
remove all the visible ductal tissue (27,29) vs. a more
conservative approach of leaving a visible rim of tissue in
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and around the nipple and areola (24,37) leads to better
nipple viability. Petit et al. (38) from Milan reported on
follow-up at 5 years of 1,001 NSMs where ELIOT and
intraoperative radiation, was applied to the retroareolar
residual nipple tissue with excellent results (nipple necrosis
rate of 3.5%). Another study from Rusby et al. (39) looked
at the microscopic anatomy of the NAC in 7 non-irradiated
and 5 irradiated nipples and found that removal of the duct
bundle in the center of the nipple and leaving a 2 or 3 mm
peripheral rim of subcutaneous tissue around the nipple
removed 96% (2 mm) and 87% (3 mm) of the ductal tissue,
respectively. The study also found that leaving a 2 or 3 mm
peripheral rim of subcutaneous tissue around the nipple
retains 50% (2 mm) and 66% (3 mm) of the vascularity of
the nipple, respectively and that radiation did not affect
the vascular density of the ductal tissue in the nipple.
These individual institutional trials and studies give some
experimental support to validate the concept of acceptable
NAC viability yet good ductal tissue clearance with the
technique of leaving small residual rims of retroareolar
breast tissue during NSMs.
The use of a “delay phenomenon” by creating a surgical
wound to improve the blood supply to the NAC prior to
the NSM has also been described with good results (40,41).
The procedure involves a periareolar incision to elevate a
plane beneath the NAC 1–3 weeks before the planned NSM
and thus stimulating improved blood supply to the wounded
tissue. Jensen et al. (41) emphasized its use, without any
NAC loss, in 20 patients with prior areolar incisions,
significant ptosis, or smokers. In lower risk patients, where
360° dermal perfusion could be preserved, however, its use
was not felt necessary.
Pathologic assessment of the NAC
Intraoperative pathologic evaluation of the NAC to
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determine preservation was initially a standard during all
NSMs to determine, intraoperatively, if the NAC could be
preserved in patients. This has recently been abandoned
by some practices (24) due to rare instances of positive
biopsies. Its use was also questioned in a poster from the
ASBS registry (42) due to the low rates of intraoperative
involvement (2/104 NAC biopsies) and 2 nipples removed
due to false positive intraoperative results which were read
as indeterminate or suspicious and were found to be cancerfree after the nipples were removed intraoperatively.
Tumescence
The use of tumescence as an aid in raising skin flaps
to decrease bleeding using lactated ringers solution
containing 1% lidocaine and dilute (1:1,000) epinephrine
has been previously described for use in mastectomies (43).
Tumescence was not shown to be an independent variable
affecting post-operative complications including infection,
flap necrosis, hematoma, seroma, or epidermolysis in two
separate studies of non-NSMs performed by Khavanin
et al. (44) and Abbott et al. (45). It has not been well studied
in NSM patients and is currently being used as an aid in some
institutions to decrease bleeding with sharp (scissor or knife)
dissection to avoid electrocautery thermal injury to the skin
but should be used with caution because of the temporary
vasoconstrictive properties of the epinephrine. I could only
find one paper which statistically evaluated tumescence in
NSM but solely related to expander reconstruction in 966
patients undergoing SSM and NSM (46) which found that
tumescence was an independent risk factor associated with
increased flap necrosis (12.8% with tumescence vs. 6.7%
without) in those patients who had high intraoperative
expander fill volumes (>66% maximal fill volume).
Surgeon experience
There is suggestive evidence and good reason to believe that
surgical experience plays a role in reducing complications
and improving outcomes in NSM but only one study
performed by Gould et al. (47) specifically analyzed surgical
experience with complications, specifically nipple necrosis
rates. In this study, there was no significant reduction in
nipple loss rates with surgeon experience of 1–2 cases
(15%) vs. 3–10 cases (23%) vs. >10 cases (20%). This study,
however, goes against other institutional experiences with
larger numbers of cases showing improved complication
rates as surgical experience and technique improves
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(13,24,27,32,34). Garwood et al. (13) in the 2-cohort study
showed a significant decrease in necrotic skin complications
(30% to 13%) and an improvement in nipple survival (80%
to 95%) with a later cohort of NSM patients performed
from 2005 to 2007 compared to an earlier cohort from
2001 to 2005. A retrospective study by Colwell et al. (34) of
500 consecutive NSMs from 2007 to 2012 showed a 5-year
trend towards inferolateral/inframammary incisions with
lower complication rates shown by multivariate analysis
[odds ratio (OR), 0.018; 95% CI, 0.00260–0.12089] which
helped to modified their subsequent incisions. Crowe et al.
showed improvements in NAC viability comparing a 2004
study (48) of 54 NSMs vs. a 2008 paper (27) of 149 NSMs
with the later paper using only laterally and the earlier
paper using medially placed incisions without NAC loss in
their later experience.
Selection factors
Surgical selection criteria have to be considered when
performing NSMs. Reviewed studies showed no difference
in complication rates (30,47) or patient satisfaction rates (10)
when the NSM was performed for cancer (therapeutic)
or for prophylactic reasons. Bilateral NSM procedures
compared to unilateral procedures, in the study by Wagner
et al. (30), showed no increase in complication rates as well.
A single institution retrospective review from 2003 to 2011
by Gould et al. (47) comparing 113 NSM cases to a matched
group of 120 SSM controls (28% vs. 27%) also found no
significant differences in overall complication rates.
Patient specific selection criteria, however, does affect
the outcome of NSMs. The effect of these patient specific
variables on complication rates have not been well studied
but has been best described by Gould et al. (47) in a
series of 73 women who underwent NSMs from 2003 to
2011. BMI, diabetes mellitus, hypertension (HTN), and
smoking showed a nonsignificant trend towards worsening
complications of nipple necrosis. Large bra cup size (C or
larger) was the only statistically significant patient factor
with a higher nipple necrosis rate of 34% compared to
only 6% with B or smaller cup sizes. Djohan et al. (32),
in his patient satisfaction survey of 78 NSM patients,
also correlated lower patient satisfactions and increased
complications with larger breasts and increased BMI. BMI,
smoking and preoperative radiation were associated with
higher total complication rates in the study by Colwell
et al. (34) which evaluated 500 NSMs from 2007 to 2012. In
the 2-cohort study by Garwood et al. (13) smoking was also
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a statistically relevant independent variable associated with
increased skin/nipple necrosis rates.
Reconstruction methods
Reconstruction method has also been linked to complications
associated with NSM. Endara et al. (26) reported a
pooled analysis study which compared 5 2-stage implant
reconstruction studies vs. 5 direct to implant reconstruction
studies vs. 2 autologous reconstruction studies and resulted
in complication rates of 52.8%, 16.7%, and 23.7%
with nipple necrosis rates of 4.5%, 4.1%, and 17.3%,
respectively. Gould et al. (47) showed no significant effect
of reconstruction type on nipple necrosis complications
in the 113 NSM cases evaluated but there was a trend
toward higher nipple necrosis rates with autologous vs.
either 2-stage or direct to implant reconstructions (40%
vs. 18.5%, P=0.23). In comparing the 2-stage vs. the direct
to implant reconstruction, Colwell et al. (34) did not see a
difference in complication rates in the 500 NSMs evaluated
however, with experience they have developed selection
criteria using the 2-stage reconstruction more selectively in
patients at higher risk of nipple or skin flap necrosis (e.g.,
smokers, higher BMI). In Garwood et al.’s (13) 2-cohort
study, a higher rate of necrotic skin complications resulted
with immediate implant reconstruction in their initial
cohort of NSM patients causing them to switch to 2-stage
reconstructions in their later cohort of NSM patients with a
reduction in the complication rate. In that study, autologous
reconstruction still accounted for the highest skin necrosis
complication rates of all of the reconstruction techniques
(37% autologous complication rate vs. 18% for direct to
implant vs. 7% for 2-stage reconstruction).
The inframammary nipple sparing technique (Figure 2)
Our initial experience and technique of NSM from 1988 to
2007 including 67 patients has been previously described (49)
with the majority of our procedures performed
prophylactically (79%). We have now performed over 600
NSMs with 95% performed by one breast surgeon (AYA)
and one plastic surgeon (CAS). Since our initial paper, we
have seen a significant increase in the numbers of NSMs
performed for cancer as acceptance and eligibility has
expanded.
Our technique involves a coordinated approach with our
reconstructive surgeons especially as it relates to patient
factors including comorbidities and breast size which have
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been shown to have significant impacts on outcomes. If
large breast size or significant ptosis is felt to affect outcome,
we have adopted Dr. Spear’s described technique (50)
of a staged reduction mastopexy and delayed NSM, if the
clinical situation allows. Previous augmentation, previous
breast surgery, and even prior radiation have not been
absolute contraindications for the procedure in our practice.
We perform MRI preoperatively in all our patients
who are felt to be NSM candidates to rule out possible
mammographic and ultrasound occult tumors in high-risk
patients choosing risk reducing NSM and to determine
eligibility of NSM in early breast cancer patients. We will
allow multifocality as long as the tumors are >2 cm from the
nipple and the disease is contained to one quadrant.
We begin by marking out symmetrical inframammary
incisions with our plastic surgeon. The incision length
varies from 8–11 cm depending on the breast anatomy
in order to obtain appropriate exposure. Larger incisions
can be required in some of the larger breasts or in
patients with dense breast tissue where the skin is fairly
taught. We have performed longer, more medially base
inframammary incisions to allow for internal mammary
artery access for deep inferior epigastric perforator (DIEP)
flap reconstructions in selected cases. The incisions are
planned to lie in the new inframammary fold as determined
preoperatively by the reconstructive surgeons (usually about
7.5–8.0 cm from the nipple). Once the incision is made, the
superior skin flap is everted with the non-dominant hand
and the breast tissue retracted inferiorly with two Adair
clamps. The plane between the subcutaneous fat and the
glandular tissue is developed to preserve the dermal blood
supply. We have used sharp knife dissection but typically use
the Peak PlasmaBladeTM radiofrequency device (Medtronic,
Palo Alto, CA, USA). We do not use tumescence in order
to prevent any short-term effect of vasoconstriction related
to the epinephrine. Care must be taken while raising the
initial inframammary flap below the nipple because this is
the most ischemic part of the skin flap and surgeons often
strip too much of the subcutaneous fat in this area exposing
the dermal vessels to injury. The breast tissue is freed using
this skin eversion technique past the posterior aspect of
the NAC with only a small approximately 2–3 mm thick
rim of breast tissue visibly left under the NAC. The nipple
itself is not inverted and cored, in our technique, to prevent
increased risks of nipple ischemia. Once the skin flap is
developed to a plane where direct visualization is impossible
by the skin eversion technique, lighted fiberoptic retraction
(Invuity TM, Invuity, San Francisco, CA or LightMat TM,
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Figure 2 Inframammary nipple sparing mastectomy technique. (A) Preoperative positioning and marking inframammary folds; (B)
inframammary incision; (C) everting skin edges and beginning flap dissection; (D) flap dissection above the nipple with fiberoptic retractor;
(E) dissection of breast off pectoralis muscle; (F) dissection of axillary breast tail; (G) retroareolar biopsy; (H) postoperative appearance after
direct to implant reconstruction.

Cura Surgical, Geneva, IL, USA) is used to visualize the
plane superiorly up to the infraclavicular region, medially
to the sternum, and laterally to the latissimus. Care is taken
to preserve the intercostal perforators coming medially off
the sternum which can supply a significant vascular supply
to the skin flaps. Finally, electrocautery is used to remove
the breast off the pectoralis major muscle. The axillary tail
of the breast is the highest and most difficult to visualize,
so this region is typically dissected last so as to use the
countertraction of the breast to better visualize and remove
these last breast/skin attachments. A retroareolar biopsy is
then taken as a shave biopsy underneath the nipple and sent
for intraoperative frozen section analysis and if positive for
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cancer, the NAC is removed through a separate horizontal
elliptical incision during the same procedure. The breast
tissue is often weighed by the plastic surgeons to help them
determine the subsequent reconstruction volumes. The
skin flaps are then visualized and trimmed, if necessary, to
remove any residual breast tissue and to ensure even flaps.
SLN biopsies are performed only in therapeutic cancer
cases through a small separate axillary incision which can
also be used to help visualize and assist in the removal of
the axillary breast tissue. Tc99 is used alone without using
either methylene blue or isosulfan blue dye to prevent
the vasoconstriction associated with the blue dyes and
potential effects on nipple viability. We use intraoperative
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skin angiography (SPY EliteTM, Novadaq, Ontario, Canada)
in most of our cases at two separate time points, after the
mastectomy and after the reconstruction to evaluate the
skin flaps. There is limited data to quantify the absolute
risk of skin flap necrosis with this device but we have found
it helpful to identify possible areas of concern which we
will monitor more closely. Since we use intraoperative
skin angiography, we do not use tumescence since it causes
significant vasoconstriction and poor visualization of the
dermal vessels during angiography, making any predictions
of skin/nipple viability nearly impossible. An upper body
warmer (Bair Hugger TM , 3M, St. Paul, MN, USA) is
kept on our patients for the first 24 hours to help prevent
vasoconstriction. For post-operative pain control, we have
used a variety of methods including Marcaine pumps (On-Q,
Halyard Health, Irvine, CA, USA) placed subcutaneously
under the skin flaps as well as pre-operative pectoral nerve
blocks and more recently liposomal bupivacaine (ExparelTM,
Pacira Pharmaceuticals, Parsippany, NJ, USA) injected into
the pectoral muscle just prior to reconstruction.
Discussion
The concept and technique of NSM was originally
described by Freeman in the 1960’s (51) but it was only
described for high-risk patients since it was not accepted
for cancer patients as the dogma of radical extirpation of
cancer persisted up until the 80’s. As the BRCA gene was
identified by Mary Claire King in the 1990’s, the NSM
made a resurgence as an accepted procedure for high-risk
patients with its reintroduction by Hartmann et al. (4) and
later benefits reported in the BRCA population (5,6,8,52).
The beginning of the century then saw the use of NSMs
in cancer patients with some encouraging initial follow-up
results (10,19,26,38,53,54) as measured by short term OS
and LR rates. Of the papers with reasonable follow-up data,
Endara et al. (26) reported locoregional recurrence rates
(LRR) of 1.8% and distant metastasis rates (DM) of 2.2% in
28 pooled studies but follow-up was short ranging from 0.2–
210 months and the tumor types and characteristics were
not independently reported in the study. A meta-analysis
reported by De La Cruz et al. (19) looked at eight studies
comparing NSM with MRM/SSM with no statistically
significant differences between the treatment groups in
terms of use of adjuvant or neoadjuvant chemotherapy,
use of adjuvant radiation, estrogen receptor (ER) or
progesterone receptor (PR) status, human epidermal
growth factor receptor 2 (HER2)/neu status, lymph node
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status or tumor sizes. Five of the 8 studies compared DFS
with a 9.6% risk benefit for NSM, 5 studies compared OS
with a 3.4% risk benefit for NSM, and 8 studies evaluated
LR with a 0.4% benefit for NSM. None of these benefits
for DFS, OS, or LR were statistically significant, however.
Follow-up times ranged from 25 to 101 months. Gerber
et al. (54) compared LRR, DM, and breast cancer specific
death rates in a series of 238 patients from 1994–2000 who
were candidates for MRM with tumors greater than 2 cm
from the nipple and no skin involvement, and were then
offered either SSM, NSM, or MRM. Forty-eight patients
underwent SSM, 60 patients underwent NSM, and 130
patients underwent MRM and no significant differences
resulted after a mean follow-up of 101 months (LRR:
10.4% SSM, 11.7% NSM, 11.5% MRM, P=0.974; DM:
25% SSM, 23.3% NSM, 26.2% MRM, P=0.916; breast
cancer specific death: 20.8% SSM, 21.7% NSM, 21.5%
MRM, P=0.993). The largest prospective trial reporting
outcomes of NSM for cancer at 13-year median follow-up
was from the Karolinska Institutet in Sweden and reported
by Benediktsson et al. (53). They followed 216 patients from
1988 to 1994 who underwent unilateral NSM for a variety
of cancers (13.3% DCIS, 33.3% stage I, 37.9% stage II,
15.3% stage III) and showed a DFS of 51.3%, OS of 76.4%,
LRR of 24.1%, and DM rate of 20.3%. The OS rates were
considered acceptable compared to other Swedish trials
of MRM at that time. The LRR was considered high and
the follow-up of the patients who had a LRR (most had
repeated local excisions and some with radiation therapy as
well) showed no effect on their OS which is not the usual
outcome for patients with recurrences after mastectomy.
The Benediktsson study included a high percentage of
patients with multifocality (73.6%), tumors >2 cm (35%),
patients with positive lymph nodes (40.3%) and also used an
older, less aggressive surgical technique for full breast tissue
removal which may have also accounted for the higher LRR.
Cancer specific indications are not being specifically
addressed in this paper but were available in many of the
articles reviewed. There is no unanimity in the selection of
cancer patients across many of the articles written on NSM.
It can be argued however, that given the current available
studies and lack of long-term cancer outcome, careful
patient selection of patients undergoing NSM should
be considered. These patients typically include isolated
tumors <2.5 cm, >2 cm from the nipple, and without skin
involvement.
During the initial introduction of NSM to both highrisk and cancer patients, it was felt that complication
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Table 4 Studies showing NSM complication rates

Complications [n (%)]

Number of procedures
[patients]

Hematoma

Infection

Flap necrosis

Nipple necrosis

Implant loss

UC-SF, 2012 (11)

657 [428]

N/A

117 (17.8)

78 (11.9)

23 (3.5)

56 (9.9)

MSKCC, 2011 (12)

353 [200]

0 (0)

6 (2.0)

69 (19.5)

13 (3.5)

3 (1.0)

MD Anderson, 2012 (30)

54 [33]

N/A

0 (0)

6 (10.0)

3 (5.6)

Mass General, 2014 (34)

482 [267]

Study institution, year

Milan, 2009 (38)

1,001 [1,001]

N/A

8 (1.7)

16 (3.3)

25 (5.2)

21 (4.4)

9 (1.9)

N/A

20 (2.0)

N/A

35 (3.5)

43 (4.3)

NSM, nipple sparing mastectomy; N/A, not available.

rates especially for skin/nipple necrosis would be too
high to justify its use. It took time to implement its use in
many programs but as the initial results began showing
acceptable complication rates (Table 4), the technique took
hold so that its use became universally accepted though
individual selection criteria vary. Nipple and skin flap
necrosis rates have typically fallen to rates between 5–10%
with most being treated conservatively without full nipple
loss. Complication rates have also fallen with improved
experience and technical improvements as was seen in the
papers by Garwood et al. (13) and Colwell et al. (34) where
keeping the incisions away from the nipple (encompassing
<30% of the NAC) and using inframammary incisions
improved their complications. Better understanding of
the NAC and skin flap blood supply as shown by O’dey
et al. (36) and van Deventer (35) have also improved our
ability to place incisions away from the major blood supply,
the medial internal mammary artery, and have helped us
understand the ability of the nipple to survive with minimal
2–3 mm rims of residual periareolar tissue while still
removing the majority of the ductal tissue.
Developing the skin flaps and preserving blood supply
has also been enhanced by our understanding of the
vascular anatomy but it should also be noted that there
is significant patient variability in skin flap thickness
required to adequately remove the majority of the breast
tissue while preserving the dermal blood supply. Figure 3
depicts a picture of two separate mammograms of two
totally different patients where the skin flap thickness
needs to be varied. A smaller lean patient will typically
have a thin subdermal fat plane and thus require a thinner
flap to remove all the breast tissue while maintaining the
dissection in the glandular-dermal plane to keep the dermal
vasculature intact. A larger patient can have a thicker
subdermal fat plane, especially away from the NAC and care
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must be taken to not make the flap so thin that most of the
subdermal fat is dissected away (lipo-dermal plane) which
will remove more dermal vasculature and thus increase flap
necrosis rates and complications.
The use of sharp (knife) vs. electrocautery dissection
in raising the anterior skin flap is operator dependent.
Sharp dissection often leads to increase blood loss and
tumescence is often considered. Though there are no
specific papers evaluating the risk of complications with
NSM alone, tumescence has been used in NSM with
acceptable outcomes (44). I personally like to use the peak
PlasmaBlade TM (Medtronic, Palo Alto, CA, USA) and
do not use tumescence while raising my skin flaps since
the PlasmaBlade TM causes less thermal injury than the
standard electrocautery due to a more precise area of action,
especially when using the cutting function. I do not like
the temporary vasoconstriction which occurs with the use
of epinephrine with the use of tumescence. In my practice,
we also use the SPY EliteTM (Novadaq, Ontario, Canada)
intraoperative skin perfusion testing of the flaps after our
mastectomies and after our reconstructions to evaluate our
skin flap perfusion. This has helped us to better evaluate
our surgical techniques in real time and gives us immediate
feedback as to the vascular integrity of our flaps. Though
there are few publications on its ability to predict flap
necrosis in NSM (55), we find it a good qualitative perfusion
test that has been able to help predict skin loss in virtually
all our cases where it has occurred. The use of tumescence
and associated vasoconstriction significantly affects the
intraoperative perfusion testing, making the test difficult to
interpret.
In the studies reviewed, patient selection factors
had a significant effect on both cosmetic outcomes and
complication rates. Most of the studies of NSM were highly
selective in their patient populations and current smokers
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A

B

Figure 3 Mammogram depiction of raising the glandular-dermal plane. (A) Patient with thin subdermal fat plane; (B) patient with thicker
subdermal fat plane.

as well as high BMI, large or ptotic breast, or patients
with prior breast irradiation were excluded from NSMs
(12,24,30,56). All of these factors seem to contribute to
increased complications in the various studies reviewed
which analyzed these patient factors (13,32,34,47) and
should be carefully considered when selecting patients as
candidates for NSM.
Overall cosmesis and patient satisfaction have been
shown to be good to excellent in the NSM studies reviewed
(10,28,31-33,54) and there are definite improvements
seen in aesthetic outcomes in the studies comparing
SSM with NSM (18,33). Complication rates have been
shown to negatively affect satisfaction scores to a greater
degree in prophylactic mastectomy patients as compared
to the patients undergoing mastectomies for cancer (57).
Dissatisfaction with nipple sensation and arousal scores
associated with NSMs are common (32) though there have
been no technical methods shown to improve these results.
The only technical factors considered in the reviewed
studies that helped improve nipple necrosis complications
and patient cosmesis and satisfaction were incision
placement away from the nipple which deceased nipple
necrosis rates (33) and non-radial incisions which decreased
nipple lateralization (28,32).
There have been several methods used to try to perform
NSMs on larger or ptotic breasted women. We have
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preferred a staged reduction mastopexy procedure as
described by Spear et al. (50), especially for prophylactic
patients whose surgeries can be delayed. Full-thickness
nipple grafting has also been used and is well described
but is associated with increased nipple losses. Dietz
et al. (58) has also described a unique technique of nipple
preservation with a reduction procedure performed during
the surgery and preserving the dermal vessels to the NAC
by deepithelializing the surrounding skin of the nipple to
perform the reduction yet preserve the NAC vasculature
without a full-thickness graft.
The use of an endoscopic technique in performing
NSMs for cancer patients has also been described by
Sakamoto et al. (59,60) from Japan who uses a combination
of an axillary and periareolar incision to perform the
dissection off of the pectoralis fascia and the anterior skin
flaps, respectively. The axillary incision is first used for the
SLN biopsy. They had good results in their initial paper (59)
including 87 patients from 2002 to 2005 but noted
significantly higher rates of nipple necrosis with nipple
coring (41%) vs. non-coring (18%) of the nipple. The
follow-up paper from 2016 (60) included 404 patients and
421 breasts with a very acceptable LRR of 2.6% after a
median follow-up of 61 months. Age <40 years, stage III
cancer, and inadequate surgical margins were significant
variables associated with LRR.

gs.amegroups.com

Gland Surg 7(3):273-287

Ashikari et al. NSM techniques

284

In regards to reconstructive techniques, current studies
would suggest that autologous reconstruction is associated
with increased complication rates when performed
with NSMs (13,26,47). Despite these initial concerns,
autologous reconstruction has its benefits and should not
be abandoned as an option in well selected patients. In our
particular practice, direct to implant reconstruction has
given excellent immediate cosmetic results in the majority
of patients undergoing NSM with acceptable complication
rates and can still be an option in larger or ptotic patients
in combination with prior reduction mastopexy (50). It also
has the added benefit of avoiding an unnecessary second
procedure for the patient. We routinely use acellular
dermal matrix (Alloderm, Allergan, Dublin, Ireland) for
our direct to implant reconstructions and have not seen any
specific increase in complication rates (61) and have even
seen benefits in reduced capsular contracture rates, even in
irradiated patients (62).

changes in the technique such as staged reductions, the use
of expanders, or even the decision to abandon a NSM and
perform a SSM with removal of the nipple in select cases.
Coordinated planning of the surgery with an experienced
cancer and reconstructive team is of utmost importance to
obtain the best patient outcomes. Continual monitoring of
complication rates as well as cancer specific outcomes will
also ensure the best quality of care for your patients.

Conclusions
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